4.7 Article

Genetic Ablation of Fgf23 or Klotho Does not Modulate Experimental Heart Hypertrophy Induced by Pressure Overload

Related references

Note: Only part of the references are listed.
Article Cardiac & Cardiovascular Systems

Molecular and structural transition mechanisms in long-term volume overload

Belal A. Mohamed et al.

EUROPEAN JOURNAL OF HEART FAILURE (2016)

Article Biochemistry & Molecular Biology

Up-regulation of FGF23 release by aldosterone

Bingbing Zhang et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)

Article Urology & Nephrology

Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production

Valentin David et al.

KIDNEY INTERNATIONAL (2016)

Article Cardiac & Cardiovascular Systems

Soluble klotho and mortality: The Ludwigshafen Risk and Cardiovascular Health Study

Vincent M. Brandenburg et al.

ATHEROSCLEROSIS (2015)

Article Cardiac & Cardiovascular Systems

Membrane-bound Klotho is not expressed endogenously in healthy or uraemic human vascular tissue

Rik Mencke et al.

CARDIOVASCULAR RESEARCH (2015)

Article Endocrinology & Metabolism

Experimental Myocardial Infarction Upregulates Circulating Fibroblast Growth Factor-23

Olena Andrukhova et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2015)

Article Cardiac & Cardiovascular Systems

Volume Overload and Adverse Outcomes in Chronic Kidney Disease: Clinical Observational and Animal Studies

Szu-Chun Hung et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2015)

Article Urology & Nephrology

Soluble Klotho Protects against Uremic Cardiomyopathy Independently of Fibroblast Growth Factor 23 and Phosphate

Jian Xie et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)

Article Cardiac & Cardiovascular Systems

Pathophysiological impact of serum fibroblast growth factor 23 in patients with nonischemic cardiac disease and early chronic kidney disease

Miki Imazu et al.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2014)

Article Cardiac & Cardiovascular Systems

Fibroblast Growth Factor-23, Cardiovascular Prognosis, and Benefit of Angiotensin-Converting Enzyme Inhibition in Stable Ischemic Heart Disease

Jacob A. Udell et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)

Article Transplantation

FGF23 protein expression in coronary arteries is associated with impaired kidney function

Natalie A. van Venrooij et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)

Article Multidisciplinary Sciences

Dynamic regulation of FGF23 by Fam20C phosphorylation, GalNAc-T3 glycosylation, and furin proteolysis

Vincent S. Tagliabracci et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)

Article Endocrinology & Metabolism

FGF23 is a novel regulator of intracellular calcium and cardiac contractility in addition to cardiac hypertrophy

Chad D. Touchberry et al.

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2013)

Article Medicine, Research & Experimental

Spironolactone ameliorates PIT1-dependent vascular osteoinduction in klotho-hypomorphic mice

Jakob Voelkl et al.

JOURNAL OF CLINICAL INVESTIGATION (2013)

Article Endocrinology & Metabolism

Mechanism of FGF23 processing in fibrous dysplasia

Nisan Bhattacharyya et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2012)

Article Cardiac & Cardiovascular Systems

Fibroblast Growth Factor-23 and Death, Heart Failure, and Cardiovascular Events in Community-Living Individuals CHS (Cardiovascular Health Study)

Joachim H. Ix et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)

Article Cardiac & Cardiovascular Systems

Plasma fibroblast growth factor 23, parathyroid hormone, phosphorus, and risk of coronary heart disease

Eric N. Taylor et al.

AMERICAN HEART JOURNAL (2011)

Article Medicine, Research & Experimental

FGF23 induces left ventricular hypertrophy

Christian Faul et al.

JOURNAL OF CLINICAL INVESTIGATION (2011)

Article Cardiac & Cardiovascular Systems

Midwall Fibrosis Is an Independent Predictor of Mortality in Patients With Aortic Stenosis

Marc R. Dweck et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)

Article Cardiac & Cardiovascular Systems

Differential Cardiac Remodeling in Preload Versus Afterload

Karl Toischer et al.

CIRCULATION (2010)

Article Cardiac & Cardiovascular Systems

Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population

Majd A. I. Mirza et al.

ATHEROSCLEROSIS (2009)

Article Cardiac & Cardiovascular Systems

Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease

Orlando M. Gutierrez et al.

CIRCULATION (2009)

Article Urology & Nephrology

Parathyroid hormone regulates fibroblast growth factor-23 in a mouse model of primary hyperparathyroidism

Takehisa Kawata et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)

Article Biochemistry & Molecular Biology

Ablation of vitamin D signaling rescues bone, mineral, and glucose homeostasis in Fgf-23 deficient mice

Martina Hesse et al.

MATRIX BIOLOGY (2007)

Article Multidisciplinary Sciences

Klotho converts canonical FGF receptor into a specific receptor for FGF23

Itaru Urakawa et al.

NATURE (2006)

Article Endocrinology & Metabolism

Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women

Sherri-Ann M. Burnett et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2006)

Article Biochemistry & Molecular Biology

Regulation of fibroblast growth factor-23 signaling by Klotho

H Kurosu et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2006)

Article Endocrinology & Metabolism

FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis

T Shimada et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2004)

Article Medicine, Research & Experimental

Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism

T Shimada et al.

JOURNAL OF CLINICAL INVESTIGATION (2004)